News Archive

Date: 01/14/2013
By looking at the entire DNA from a fibrous tumor, University of Michigan Comprehensive Cancer Center researchers have found a genetic anomaly that provides an important clue to improving how this cancer is diagnosed and treated.
Date: 12/11/2012
Written by: Nicole Casal Moore, 734-647-7087, ncmoore@umich.eduNicole Fawcett, 734-764-2220, nfawcett@umich.edu
Date: 12/11/2012
Mice without the anti-aging gene had a higher risk of gastrointestinal cancers, according to a study released by the University of Michigan Health System.
Date: 12/07/2012
Women undergoing chemotherapy who experience cognitive problems, commonly referred to as 'chemo brain,' displayed alterations in neurocognitive responses prior to undergoing treatment, according to data presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 4-8, 2012.
Date: 12/05/2012
Ponatinib acts against the most resistant types of chronic myeloid leukemia based on the results of a Phase I Trial, reported in the New England Journal of Medicine
Date: 12/04/2012
Many patients with early stage breast cancer -- and a low risk for recurrence -- still undergo advanced diagnostic imaging to look for metastasis, according to a study released by the University of Michigan Comprehensive Cancer Center.
Date: 12/04/2012
Tumors were reduced on bone scans, bone pain decreased after patients received cabozantinibWritten by Nicole Fawcett.
Date: 11/27/2012
About 70% of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer in the healthy breast, new research from the University of Michigan Comprehensive Cancer Center finds.
Date: 11/12/2012
Scientists from UT Southwestern Medical Center and the University of Michigan Comprehensive Cancer Center have developed an innovative model for predicting the progression of skin cancer in patients.
Date: 10/29/2012
'Comprehensive cancer center' status also renewedWritten by Nicole Fawcett

Pages